Saniye EKİNCİ, Arbay ÖZDEN ÇİFTÇİ, Feridun Cahit TANYEL, Diclehan ORHAN, Canan AKYÜZ, İbrahim KARNAK, Burak ARDIÇLI

Non-Wilms’ Renal Tumors In Childhood

Objective: To determine the outcomes, demographics, clinical and surgical characteristics of NWRT in children. Methods: Forty-three children who underwent surgery for NWRT between 1970 and 2016 were included. The charts and surgery notes were evaluated retrospectively and age, sex, complaints and physical findings at presentation, results of biochemical tests, details of surgery, pathologic findings, and the postoperative course were noted. Results: The female to male ratio was 15:28. Distribution according to histological groups were CCSK (n=14), CMN (n=10), RCC (n=7), CN (n=4), angiomyolipoma (n=2), MRT (n=2), sclerosing nephrogenic rest (n=1), renal tubular adenoma (n=1), metanephric stromal tumor (n=1), and renal adenocarcinoma (n=1). Nephroureterectomy was the most frequently used surgical treatment (n=38) (88%). The mortality rate was 21% in malignant NWRT (3 with CCSK, 2 with MRT) and 10% in benign NWRT (2 CMN) during the five-year follow up period. Conclusion: Non-Wilms renal tumors are rare in childhood. The presumptive diagnosis is usually a Wilms tumor. Hypercalcemia may be encountered. A nephroureterectomy is necessary in most cases. NSS can be performed in selected cases and under suitable conditions.

PDF

___

[1] Syed JS, Nguyen KA, Wu CQ, et al. Distinguishing pediatric and adolescent renal cell carcinoma from other renal malignancies. Pediatr Blood Cancer. 2017;64.
[2] Shamberger RC. Renal Tumors. In: Carachi R, Grosfeld JL, Azmy A, editors. The surgery of childhood tumors. New York: Springer Berlin Heidelberg; 2016. pp. 171-200.
[3] Broecker B. Non-Wilms’ renal tumors in children. Urol Clin North Am. 2000;27:463-9.
[4] Tomlinson GE, Breslow NE, Dome J, et al. Rhabdoid tumor of the kidney in the National Wilms’ Tumor Study: age at diagnosis as a prognostic factor. J Clin Oncol. 2005;23:7641-5.
[5] Glick RD, Hicks MJ, Nuchtern JG, et al. Renal tumors in infants less than 6 months of age. J Pediatr Surg. 2004;39:522-5.
[6] Argani P, Perlman EJ, Breslow NE, et al. Clear cell sarcoma of the kidney: a review of 351 cases from the National Wilms Tumor Study Group Pathology Center. Am J Surg Pathol. 2000;24:4-18.
[7] Zhuge Y, Cheung MC, Yang R, et al. Pediatric non-Wilms renal tumors: subtypes, survival, and prognostic indicators. J Surg Res. 2010;163:257-63.
[8] Leblanc A, Caillaud JM, Hartmann O, et al. Hypercalcemia preferentially occurs in unusual forms of childhood non- Hodgkin’s lymphoma, rhabdomyosarcoma, and Wilms’ tumor. A study of 11 cases. Cancer. 1984;54:2132-6.
[9] Jayabose S, Iqbal K, Newman L, et al. Hypercalcemia in childhood renal tumors. Cancer. 1988;61:788-91.
[10] Selle B, Furtwangler R, Graf N, et al. Population-based study of renal cell carcinoma in children in Germany, 1980- 2005: more frequently localized tumors and underlying disorders compared with adult counterparts. Cancer. 2006;107:2906-14.
[11] Apaydin E, Ozluk Y, Yuksel S, et al. The Value of Mitotic Count and Ki67 Proliferation Index in Congenital Mesoblastic Nephroma. Fetal Pediatr Pathol. 2016;35:376-84.
[12] Gormley TS, Skoog SJ, Jones RV, et al. Cellular congenital mesoblastic nephroma: what are the options. J Urol. 1989;142:479-89.
[13] Marsden HB, Lawler W, Kumar PM. Bone metastasizing renal tumor of childhood: morphological and clinical features, and differences from Wilms’ tumor. Cancer. 1978;42:1922-8.
[14] Weeks DA, Beckwith JB, Mierau GW, et al. Rhabdoid tumor of kidney. A report of 111 cases from the National Wilms’ Tumor Study Pathology Center. Am J Surg Pathol. 1989;13:439-58.
[15] Gooskens SL, Graf N, Furtwangler R, et al. Position paper: Rationale for the treatment of children with CCSK in the UMBRELLA SIOP-RTSG 2016 protocol. Nat Rev Urol. 2018;15:309-19.
[16] Gooskens SLM, Furtwangler R, Vujanic GM, et al. Clear cell sarcoma of the kidney: a review. Eur J Cancer. 2012;48:2219-26.
[17] Hadley GP, Sheik-Gafoor MH. Clear cell sarcoma of the kidney in children: experience in a developing country. Pediatr Surg Int. 2010;26:345-8.
[18] Saula PW, Hadley GP. Pediatric non-Wilms’ renal tumors: a third world experience. World J Surg. 2012;36:565-72.
[19] Seibel NL, Li S, Breslow NE, et al. Effect of duration of treatment on treatment outcome for patients with clearcell sarcoma of the kidney: a report from the National Wilms’ Tumor Study Group. J Clin Oncol. 2004;22:468-73.
[20] Marsden HB, Lawler W. Primary renal tumours in the first year of life. A population based review. Virchows Arch A Pathol Anat Histopathol. 1983;399:1-9.
[21] Chan HS, Cheng MY, Mancer K, et al. Congenital mesoblastic nephroma: a clinicoradiologic study of 17 cases representing the pathologic spectrum of the disease. J Pediatr. 1987;111:64-70.
[22] Geller E, Smergel EM, Lowry PA. Renal neoplasms of childhood. Radiol Clin North Am. 1997;35:1391-413.
[23] Chaudry G, Perez-Atayde AR, Ngan BY, et al. Imaging of congenital mesoblastic nephroma with pathological correlation. Pediatr Radiol. 2009;39:1080-6.
[24] Gooskens SL, Houwing ME, Vujanic GM, et al. Congenital mesoblastic nephroma 50 years after its recognition: A narrative review. Pediatr Blood Cancer. 2017;64.
[25] Furtwaengler R, Reinhard H, Leuschner I, et al. Mesoblastic nephroma--a report from the Gesellschaft fur Padiatrische Onkologie und Hamatologie (GPOH). Cancer. 2006;106:2275-83.
[26] Sandstedt B, Delemarre JF, Krul EJ, et al. Mesoblastic nephromas: a study of 29 tumours from the SIOP nephroblastoma file. Histopathology. 1985;9:741-50.
[27] Jehangir S, Kurian JJ, Selvarajah D, et al. Recurrent and metastatic congenital mesoblastic nephroma: where does the evidence stand? Pediatr Surg Int. 2017;33:1183-8.
[28] Bruder E, Passera O, Harms D, et al. Morphologic and molecular characterization of renal cell carcinoma in children and young adults. Am J Surg Pathol. 2004;28:1117- 32.
[29] Malkan AD, Loh A, Bahrami A, et al. An approach to renal masses in pediatrics. Pediatrics. 2015;135:142-58.
[30] Washecka R, Hanna M. Malignant renal tumors in tuberous sclerosis. Urology. 1991;37:340-3.
[31] Beisland C, Medby PC, Beisland HO. Renal cell carcinoma: gender difference in incidental detection and cancerspecific survival. Scand J Urol Nephrol. 2002;36:414-8.
[32] Indolfi P, Terenziani M, Casale F, et al. Renal cell carcinoma in children: a clinicopathologic study. J Clin Oncol. 2003;21:530-5.
[33] Cook A, Lorenzo AJ, Salle JL, et al. Pediatric renal cell carcinoma: single institution 25-year case series and initial experience with partial nephrectomy. J Urol. 2006;175:1456-60.
[34] Moreira DM, Gershman B, Lohse CM, et al. Paraneoplastic syndromes are associated with adverse prognosis among patients with renal cell carcinoma undergoing nephrectomy. World J Urol. 2016;34:1465-72.
[35] Gold PJ, Fefer A, Thompson JA. Paraneoplastic manifestations of renal cell carcinoma. Semin Urol Oncol. 1996;14:216-22.
[36] Agrons GA, Kingsman KD, Wagner BJ, et al. Rhabdoid tumor of the kidney in children: a comparative study of 21 cases. AJR Am J Roentgenol. 1997;168:447-51.
[37] Sebire NJ, Vujanic GM. Paediatric renal tumours: recent developments, new entities and pathological features. Histopathology. 2009;54:516-28.
[38] Flum AS, Hamoui N, Said MA, et al. Update on the Diagnosis and Management of Renal Angiomyolipoma. J Urol. 2016;195:834-46.
[39] Kacar A, Azili MN, Cihan BS, et al. Metanephric stromal tumor: a challenging diagnostic entity in children. J Pediatr Surg. 2011;46:e7-e10.